Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Quiz

Quiz: Real-World Effectiveness of Enasidenib for Relapsed/Refractory AML

 

 

True or False: First-line enasidenib demonstrates worse efficacy in the real-world setting than in clinical trials for the treatment of relapsed/refractory IDH2-mutated AML.

 

 


Advertisement

Advertisement

Advertisement